When was Lucis founded?

Lucis was founded in 2023 and raised its 1st funding round 2 years after it was founded.

Where is Lucis located?

Lucis is headquartered in Artannes-sur-indre, France.

Who is the current CEO of Lucis?

Max Berthelot of Lucis. They have also founded 1 company.

Is Lucis a funded company?

Lucis is a funded company, having raised a total of $29M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 23, 2025.

When was the latest funding round of Lucis?

Lucis' latest funding was a $***** Series A round on May 26, 2026, with participation from 3 investors. Its primary sector is Healthcare IT. In France, the Healthcare IT sector has seen $262M in funding in 2026 to date.

Where does Lucis rank among its competitors?

Lucis ranks 2nd amongst 27 active competitors, of which 10 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Enumera Molecular, which secured $12.3M in Jul, 2026.

Who are the top competitors of Lucis?

Lucis' top competitors include PocDoc, Genalyte and Lyfas. Among them, Enumera Molecular secured the most recent funding round in July, 2026.

Lucis - 2026 Company Profile, Team, Funding & Competitors

Lucis is a series A company based in Artannes-sur-indre (France), founded in 2023 by Baptiste Debever, Max Berthelot, Max Berthelot and Baptiste Debever. It operates as a Provider of personalized health insights and recommendations based on blood tests. Lucis has raised $29M in funding from General Catalyst and Singular. The company has 27 active competitors, including 10 that are funded. Its top competitors include companies like PocDoc, Genalyte and Lyfas.

Company Details

Provider of personalized health insights and recommendations based on blood tests. The company offers individuals a way to monitor biomarkers and access resources for health improvement. It facilitates blood tests at partner labs, analyzes health profiles, and provides tailored recommendations. Individuals can track results, monitor progress, and retest to assess changes over time.

Key Metrics

Founded Year

2023

Location

Artannes-sur-indre, France

Stage

Series A

Total Funding

$29M in 3 rounds

Latest Funding Round

Series A, May 26, 2026, $*****

Investors

General Catalyst & 8 more

Ranked

2^nd among 27 active competitors

Similar Companies

PocDoc & 33 more

View Lucis' full profile

Lucis has raised a total funding of $29M over 3 rounds. Its first funding round was on Jun 23, 2025. Its latest funding round was a Series A round on May 26, 2026 for $*****. 3 investors participated in its latest round. Lucis has 8 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Lucis:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 26, 2026	4061132	Series A	6231426	6399687	8269987	9287402
Dec 16, 2025	1466082	Seed	3098243	2426381	4941001	Y Combinator & 3 more
Jun 23, 2025	4279842	Seed	2739305	2038437	5213852	Y Combinator

Access funding benchmarks and valuations. Sign up today!

View details of Lucis's funding rounds and investors

The founders of Lucis are Baptiste Debever, Max Berthelot, Max Berthelot and Baptiste Debever. Max Berthelot, Zishan Zhuang and Zishan Zhuang are the CEOs of Lucis.

Here are the details of Lucis' key team members:

Baptiste Debever: Founder & CTO of Lucis.
Max Berthelot: Founder of Lucis.
Max Berthelot: Founder & CEO Lucis (YC X25) – Live 100 Healthy Years From a Simple Blood Test. of Lucis.
Baptiste Debever: Founder & CTO of Lucis.

View details of Lucis's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lucis include PocDoc, Genalyte and Lyfas. Here is the list of Top 10 competitors of Lucis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PocDoc 2017, Cambridge (United Kingdom), Seed	Provider of smartphone based rapid testing for major diseases	$12.4M	MMC Ventures, Forward Partners & 4 others	54/100
2nd	Lucis 2023, Artannes-sur-indre (France), Series A	Provider of personalized health insights and recommendations based on blood tests	$29M	Kima Ventures, Singular & 7 others	46/100
3rd	Genalyte 2007, San Diego (United States), Series E	Real-time blood diagnostics at the point of care	$142M	Redmile Group, Khosla Ventures & 15 others	46/100
4th	Lyfas 2017, Bengaluru (India), Seed	Provider of AI-based predictive and preventive digital health test and home remedy	$2.26M	IIT Kanpur, Startup Basket & 20 others	38/100
5th	Adsys 2021, Jaipur (India), Seed	Provider of AI-based device for rapid blood diagnosis	$154K	Rainmatter, Social Alpha & 2 others	36/100
6th	The Smart Lollipop 2020, Barcelona (Spain), Seed	Disease diagnosis device for healthcare providers	$318K	Ship2B Ventures, Conector & 3 others	34/100
7th	Enumera Molecular 2022, Ann Arbor (United States), Series B	Developer of liquid biopsy tools	$31M	Arboretum Ventures	33/100
8th	OBI Medical 2002, Hadsund (Denmark), Seed	Provider of solutions for calculation of arterial acid-base and blood gas status	$3.23M	Vaekstfonden, Market Maturation Fund	29/100
9th	Smart Blood Analytics 2015, Chur (Switzerland), Unfunded	Provider of artificial intelligence based blood analyzing platform	-	-	28/100
10th	Biotasmart 2025, Valencia (United States), Seed	Provider of data-driven microbiota analysis and personalized nutrition recommendation platform	$592K	Angels Capital, Enisa & 5 others	27/100